Global contract research organization (CRO) transforms its regulatory affairs and unlocks efficiency gains and greater compliance confidence.NEW YORK & SINGAPORE, April 22 (Bernama-BUSINESS WIRE) -- In a move to address the growing complexity of global regulations,
CellCarta, a globally recognized provider of CRO laboratory services for pharmaceutical research and development, and
RegASK, the Agentic AI platform redefining regulatory intelligence, today announced the results of a year-long collaboration to modernize CellCarta’s regulatory intelligence operations. By automating regulatory monitoring and intelligence generation, the partnership has reduced research cycles that previously took up to 9 hours per week to near real-time delivery.
Over the past year, CellCarta has worked closely with RegASK to accelerate the digital transformation of its regulatory affairs function. As regulatory complexity continues to increase, CellCarta, like many life science organizations, faced challenges with fragmented information sources, manual tracking of regulatory change, and limited capacity to scale monitoring across multiple geographies.
“Strengthening our regulatory intelligence capability has been a key priority for CellCarta,” said Todd Chermak, SVP and Global Business Head of Immunology and Proteomics at CellCarta. “With RegASK, we now have access to curated, AI-driven insights and automated workflows that have streamlined how we capture, interpret, act on, and share regulatory intelligence to keep teams aligned and respond to regulatory change.”
Today, CellCarta’s processes are anchored by a centralized regulatory intelligence hub, a single source of truth that consolidates regulatory signals across markets. The platform automatically captures and validates unstructured content from regulatory agencies, standards bodies, and legislative databases, transforming it into contextual updates and actionable follow-ups. Automated notifications provide immediate access to critical developments, while AI-driven summaries enable faster, better-informed decision-making across research, clinical development, and quality teams.
“Our collaboration with CellCarta shows what becomes possible when AI, automation and vertical expertise are applied to transform a regulatory affairs function over time,” said Caroline Shleifer, Founder & CEO at RegASK. “CellCarta’s teams now save time, gain clarity faster on relevant regulatory information, and act with greater coordination and confidence. In clinical research and precision medicine, this level of accuracy and responsiveness is critical because delays or gaps in regulatory intelligence directly impact drug development and market access.”
Looking ahead, CellCarta plans to deepen its use of AI across the regulatory lifecycle. The next phase involves deploying agentic AI, enabling multiple specialized AI agents to work in parallel on day-to-day regulatory tasks such as content curation and triage, impact assessment, translation, and stakeholder collaboration. As global regulations continue to expand in volume and complexity, organizations that successfully deploy AI to automate routine tasks and surface critical insights will define the next generation of regulatory excellence. They will be best positioned to remain agile, compliant and competitive in every market they serve.
About CellCartaCellCarta is a leading global CRO laboratory to the biopharmaceutical industry. With CAP accreditations and CLIA certifications for specific testing methods and facilities in Canada, USA, Belgium, Australia, and China, CellCarta provides a wide range of biomarker testing services and customized solutions to world-renowned pharmaceutical companies. By integrating analytical platforms in immunology, histopathology, proteomics, and genomics, along with sample management and logistics services, CellCarta supports the entire drug development cycle from discovery to late-stage clinical trials. Visit
cellcarta.com and connect with us on
LinkedIn and
X.
About RegASKRegASK is the AI-driven regulatory operating system for global life sciences and consumer products companies. Powered by agentic AI and a global community of more than 1,800 subject matter experts across 160+ territories, the platform detects regulatory change, assesses portfolio impact, and orchestrates compliance workflows - enabling organizations to move from passive monitoring to proactive, autonomous regulatory operations. RegASK is the first company in its category to achieve ISO/IEC 42001 certification for AI Management Systems and holds six independent certifications. To learn more about RegASK visit
regask.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20260421772109/en/ ContactMedia ContactStéphanie Bussières-Marmen, PhD
Director, Global Marketing
media@cellcarta.comReuben Chen
Head of Marketing
reuben.chen@regask.comSource : RegASK
--BERNAMA